slides · global inventory
Frame Problem
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 5,849
Current window 4,621-4,650
Pages 195
Rows per page 30
Slide function
4,621-4,650 of 5,849
03
Uses a value-chain style diagram to illustrate market fragmentation.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a visual comparison framework to contrast current standard-of-care targets (mutations/fusions) with the company's focus (ecDNA).Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Problem (Identify pain)1 hit
10
The slide uses Kaplan-Meier survival curves to illustrate the clinical problem.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The slide uses a visual 'X' to indicate the lack of efficacy for amplifications across multiple drug classes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
12
The slide uses a color-coded matrix to illustrate clinical failure or limited efficacy in amplified tumors.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
15
The slide uses a combination of microscopy images, a circular genomic plot (circos plot), and a diagram of cell division to illustrate the mechanism.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
17
The slide uses a stacked bar chart to show amplification types and a Kaplan-Meier survival curve to show patient outcomes.Boundless Bio | IPO Presentation Deck | 51 slides · Boundless Bio
Pitch deck Investment bank 1 hit
07
The chart uses color to represent education levels and bubble size to represent employment volume. The arrow indicates the shift of AI impact.Coursera | Investor Presentation Deck | 31 slides · Coursera
Pitch deck Investor relations Beat · ProblemLoop · Quick Win Big Bet1 hit
04
Uses a visual metaphor of a fax machine to emphasize the inefficiency of current medical documentation processes.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
10
Uses a visual comparison framework to illustrate the 'Goldilocks' problem of cytokine inhibition (too narrow vs. too broad).Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Beat · Problem1 hit
25
The slide uses a combination of qualitative physician sentiment and quantitative survey data to frame the problem of safety in current standard-of-care treatments.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
30
Uses a clear contrast between patient count and available treatments to frame the market opportunity.Equillium | Investor Presentation Deck | 40 slides · Equillium
Pitch deck Investor relations 1 hit
30
The slide uses a biological diagram to illustrate EGFR mutations in GBM.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
20
Uses information theory to explain why 20 binary questions can narrow down a search space of 600,000 items.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Desire1 hit
21
The chart uses a series of iterative loop icons to represent the learning process.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
06
Uses a value-chain style diagram to show the complexity of the current market.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a map-based layout to connect specific logistics pain points to the global supply chain.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a hub-and-spoke diagram to centralize the problem of neurotoxicity.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
19
The slide uses a process flow diagram to connect cellular pathology to clinical manifestations.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & Proof1 hit
06
The slide uses a three-column layout with circular callouts to emphasize demographic trends and disease prevalence.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
10
The slide uses a visual timeline/process flow to show disease progression.Mainz Biomed NV | Investor Presentation Deck | 24 slides · Mainz Biomed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses a 'media montage' approach to establish urgency and external validation of the problem.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
Matinas BioPharma | Investor Presentation Deck | 29 slidesMatinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide highlights both the clinical urgency (toxicity, resistance) and the commercial potential (orphan disease status).Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
Includes a personal testimonial/case study image of a patient (Shay) to humanize the disease.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Problem1 hit
13
The slide uses a timeline-based customer journey framework to map clinical progression against therapeutic limitations.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations Loop · Mece Breakdown1 hit
09
The slide highlights the lack of clear standard of care in later lines of therapy, framing the problem for a potential new therapeutic intervention.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Pattern Hunter1 hit
13
The slide uses a timeline-based journey map to contrast standard treatments with unmet clinical needs.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
28
The slide uses a timeline-based framework to contrast treatment options with clinical limitations.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · Traction1 hit
07
Uses a before-after framing to establish the problem (left) and the solution/impact (right).Talkspace | Investor Conference Presentation Deck | 13 slides · Talkspace
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit